Puerto Rico Bolsters Its Life-Sciences Hub With R&D, Start-Up Initiatives
Executive Summary
In the past year, Puerto Rico formed a consortium of clinical trial sites, launched a funding program for entrepreneurs and created a technology transfer office – all achievements touted at the Biolatam biotech conference in San Juan.
You may also be interested in...
Puerto Rico’s Molecular Sciences Research Center Signals Resurgent Industry
The five-year old center is to include the island’s first preclinical facility. Researchers there are working on an HIV vaccine with support from Amgen, Lilly and the US National Institutes of Health.
Companies Reveal Hurdles In Providing Drugs Via Expanded Access Programs
GSK, Stealth BioTherapeutics and Blueprint Medicines discuss the difficulties getting participation of physicians, the excessive cost of expanded access, and whether physicians should report research data.
Current Pathways For Rare Disease Drugs Are Not Optimal, US FDA’s Califf Says
Anticipating a ‘tsunami of therapies’ for rare diseases, commissioner says the agency will have to think of creative approaches and employ regulatory flexibility for them. FDA considers copying the oncology center’s Project Facilitate for expanded access to other diseases.